RELX stock: STM investor seminar set for November 3

RELX will hold an investor seminar on its scientific, technical and medical publishing business on Tuesday, November 3. The event is the next scheduled focus for investors after the group reaffirmed its full-year outlook in a trading update, according to the Investing.com transcript credited to Reuters.

Growth remains broad based

RELX reported 7 percent underlying revenue growth in the first nine months of 2026. Legal revenue rose 10 percent, Risk increased 8 percent and STM advanced 6 percent, while Exhibitions grew 4 percent. Disruption in the Middle East reduced Exhibitions growth by about 3 percentage points.

The STM seminar is expected to give investors more detail on LeapSpace, the group's research-focused AI workspace. Article submissions in the division increased by more than 20 percent year to date, while management said LeapSpace usage was growing rapidly but had not yet made a material contribution to revenue.

AI adoption shapes the outlook

In Legal, adoption of the Lexis+ Protégé platform has passed 50 percent of the United States revenue mix. The vast majority of new sales and a comfortable majority of renewals are moving to the AI-enabled platform, supporting the group's shift toward higher-growth analytics and decision tools.

In Risk, more than 90 percent of revenue comes from machine-to-machine interactions. Management expects continued demand for AI-enabled analytics, fraud prevention and identity solutions as customers respond to synthetic identities, deepfakes and other emerging threats.

RELX stock traded at 35.85 euros on Lang & Schwarz at 5:03 p.m. CET on Sunday, November 1, 2026; investors can use the real-time quote of RELX stock.

The FTSE 100 provides the relevant market backdrop for RELX's London-listed shares.

More news and analyses on RELX stock will track the seminar and its implications for the group's AI-led growth strategy.